Regulation of SERCA pumps expression in diabetes

Cell Calcium

Volumn 56, Issue 5, 2014, Pages 302-310

  Zarain Herzberg, Angel ^a   García Rivas, Gerardo ^b,c   Estrada Avilés, Rafael ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^c HOSPITAL ZAMBRANO HELLION   (Mexico)

Author keywords

Diabetic cardiomyopathy; Heart; Pancreas; Sarco endoplasmic reticulum Ca2+ ATPase

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARDIOVASCULAR AGENT; INSULIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2B; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 3; UNCLASSIFIED DRUG; ATP2A2 PROTEIN, HUMAN; CALCIUM;

ACYLATION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL METABOLISM; CELL PROLIFERATION; CYTOSOL; DIABETIC CARDIOMYOPATHY; DIABETOGENESIS; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME REGULATION; GENE THERAPY; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INTRACELLULAR TRANSPORT; MUSCLE CONTRACTION; MUSCLE EXERCISE; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; BIOSYNTHESIS; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

CALCIUM; DIABETES MELLITUS, TYPE 1; DIABETIC CARDIOMYOPATHIES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INSULIN; INSULIN-SECRETING CELLS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84912521201     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.09.005     Document Type: Review

References (94)

1. Hovnanian A. SERCA pumps and human diseases. Subcell. Biochem. 2007, 45:337-363.
2. Lehnart S.E., Schillinger W., Pieske B., Prestle J., Just H., Hasenfuss G. Sarcoplasmic reticulum proteins in heart failure. Ann. N. Y. Acad. Sci. 1998, 853:220-230.
3. Bers D.M. Excitation-contraction coupling and cardiac contractile force 2001, Kluwer Academic Publishers, Dordrecht, Boston. 2nd ed.
4. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
5. Bers D.M. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 2008, 70:23-49.
6. Yano K., Zarain-Herzberg A. Sarcoplasmic reticulum calsequestrins: structural and functional properties. Mol. Cell. Biochem. 1994, 135:61-70.
7. Beard N.A., Laver D.R., Dulhunty A.F. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Progr. Biophys. Mol. Biol. 2004, 85:33-69.
8. Beard N.A., Wei L., Dulhunty A.F. Control of muscle ryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen. Clin. Exp. Pharmacol. Physiol. 2009, 36:340-345.
9. Tada M., Toyofuku T. Molecular regulation of phospholamban function and expression. Trends Cardiovasc. Med. 1998, 8:330-340.
10. Boudina S., Abel E.D. Diabetic cardiomyopathy revisited. Circulation 2007, 115:3213-3223.
11. Belke D.D., Dillmann W.H. Altered cardiac calcium handling in diabetes. Curr. Hypertens. Rep. 2004, 6:424-429.
12. Fredersdorf S., Thumann C., Zimmermann W.H., et al. Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: in vivo and in vitro data. Cardiovasc. Diabetol. 2012, 11:57.
13. 2+ in the heart during diabetes. Cardiovasc. Res. 1997, 34:41-47.
14. Hasenfuss G., Meyer M., Schillinger W., Preuss M., Pieske B., Just H. Calcium handling proteins in the failing human heart. Basic Res. Cardiol. 1997, 92(Suppl 1):87-93.
15. Lacombe V.A., Viatchenko-Karpinski S., Terentyev D., et al. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R1787-R1797.
16. Suarez J., Scott B., Dillmann W.H. Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R1439-R1445.
17. Bai S.Z., Sun J., Wu H., et al. Decrease in calcium-sensing receptor in the progress of diabetic cardiomyopathy. Diabetes Res. Clin. Pract. 2012, 95:378-385.
18. Voulgari C., Papadogiannis D., Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc. Health Risk Manag. 2010, 6:883-903.
19. Horakova L., Strosova M.K., Spickett C.M., Blaskovic D. Impairment of calcium ATPases by high glucose and potential pharmacological protection. Free Radic. Res. 2013, 47(Suppl. 1):81-92.
20. Tang W.H., Cheng W.T., Kravtsov G.M., et al. Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress. Am. J. Physiol. Cell Physiol. 2010, 299:C643-C653.
21. Kota S.K., Kota S.K., Jammula S., Panda S., Modi K.D. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications. Diabetes Technol. Therap. 2011, 13:1155-1160.
22. 2+/calmodulin-dependent protein kinase mediates glucose toxicity-induced cardiomyocyte contractile dysfunction. Exp. Diabetes Res. 2012, 2012:829758.
23. Stanhope K.L., Schwarz J.M., Keim N.L., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 2009, 119:1322-1334.
24. 2+ handling and myofilament responsiveness. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H964-H972.
25. Wold L.E., Dutta K., Mason M.M., et al. Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. J. Mol. Cell. Cardiol. 2005, 39:297-307.
26. Kralik P.M., Ye G., Metreveli N.S., Shem X., Epstein P.N. Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes. Cardiovasc. Toxicol. 2005, 5:285-292.
27. Zarain-Herzberg A., Yano K., Elimban V., Dhalla N.S. Cardiac sarcoplasmic reticulum Ca(2+)-ATPase expression in streptozotocin-induced diabetic rat heart. Biochem. Biophys. Res. Commun. 1994, 203:113-120.
28. Takada A., Miki T., Kuno A., et al. Role of ER stress in ventricular contractile dysfunction in type 2 diabetes. PLoS ONE 2012, 7:e39893.
29. 2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia. Cardiovasc. Diabetol. 2010, 9:8.
30. Assayag P., Charlemagne D., de Leiris J., et al. Senescent heart compared with pressure overload-induced hypertrophy. Hypertension 1997, 29:15-21.
31. Azhar G., Zhang X., Wang S., Zhong Y., Quick C.M., Wei J.Y. Maintaining serum response factor activity in the older heart equal to that of the young adult is associated with better cardiac response to isoproterenol stress. Basic Res. Cardiol. 2007, 102:233-244.
32. Kaplan P., Jurkovicova D., Babusikova E., et al. Effect of aging on the expression of intracellular Ca(2+) transport proteins in a rat heart. Mol. Cell. Biochem. 2007, 301:219-226.
33. 2+-ATPase in human heart failure. Circulation 2005, 111:988-995.
34. Sena S., Hu P., Zhang D., et al. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. J. Mol. Cell. Cardiol. 2009, 46:910-918.
35. Domenighetti A.A., Danes V.R., Curl C.L., Favaloro J.M., Proietto J., Delbridge L.M. Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca(2+) and proton flux dysregulation. J. Mol. Cell. Cardiol. 2010, 48:663-672.
36. Brady M., Koban M.U., Dellow K.A., Yacoub M., Boheler K.R., Fuller S.J. Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes. Cardiovasc. Res. 2003, 60:347-354.
37. Takizawa T., Arai M., Tomaru K., et al. Transcription factor Sp1 regulates SERCA2 gene expression in pressure-overloaded hearts: a study using in vivo direct gene transfer into living myocardium. J. Mol. Cell. Cardiol. 2003, 35:777-783.
38. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6611-6616.
39. Hu Y., Belke D., Suarez J., et al. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ. Res. 2005, 96:1006-1013.
40. Fricovsky E.S., Suarez J., Ihm S.H., et al. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 303:R689-R699.
41. Clark R.J., McDonough P.M., Swanson E., et al. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 2003, 278:44230-44237.
42. Yokoe S., Asahi M., Takeda T., et al. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy. Glycobiology 2010, 20:1217-1226.
43. Kim H.S., Woo J.S., Joo H.J., Moon W.K. Cardiac transcription factor Nkx2.5 is downregulated under excessive O-GlcNAcylation condition. PLoS ONE 2012, 7:e38053.
44. Donath M.Y., Jenni R., Brunner H.P., et al. Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans. J. Clin. Endocrinol. Metab. 1996, 81:4089-4094.
45. Cox E.J., Marsh S.A. Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A/HDAC1/2 complex in the heart. Cardiovasc. Diabetol. 2013, 12:101.
46. Boule N.G., Weisnagel S.J., Lakka T.A., et al. Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care 2005, 28:108-114.
47. Viru M. Differences in effects of various training regimens on metabolism of skeletal muscles. J. Sports Med. Phys. Fit. 1994, 34:217-227.
48. Akbarpour M. The effect of aerobic training on serum adiponectin and leptin levels and inflammatory markers of coronary heart disease in obese men. Biol. Sport/Inst. Sport 2013, 30:21-27.
49. Safwat Y., Yassin N., Gamal El Din M., Kassem L. Modulation of skeletal muscle performance and SERCA by exercise and adiponectin gene therapy in insulin-resistant rat. DNA Cell Biol. 2013, 32:378-385.
50. deGoh K.P., Lee H.Y., Lau D.P., Supaat W., Chan Y.H., Koh A.F. Effects of resveratrol in patients with Type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure. Int. J. Sport Nutr. Exer. Metab. 2014, 24:2-13.
51. Middlekauff H.R., Vigna C., Verity M.A., et al. Abnormalities of calcium handling proteins in skeletal muscle mirror those of the heart in humans with heart failure: a shared mechanism?. J. Card. Fail. 2012, 18:724-733.
52. 2+-ATPase. J. Pharmacol. Exp. Therap. 1999, 290:227-234.
53. Namekata I., Hamaguchi S., Wakasugi Y., Ohhara M., Hirota Y., Tanaka H. Ellagic acid and gingerol, activators of the sarco-endoplasmic reticulum Ca(2)(+)-ATPase, ameliorate diabetes mellitus-induced diastolic dysfunction in isolated murine ventricular myocardia. Eur. J. Pharmacol. 2013, 706:48-55.
54. Wang M., Zhang W.B., Zhu J.H., Fu G.S., Zhou B.Q. Breviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca(2+)-cycling proteins in streptozotocin-induced diabetic rats. Acta Diabetol. 2010, 47(Suppl 1):209-218.
55. Pillai J.B., Gupta M., Rajamohan S.B., Lang R., Raman J., Gupta M.P. Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1545-H1553.
56. Pillai J.B., Chen M., Rajamohan S.B., et al. Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the alpha-myosin heavy chain expression. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1388-H1397.
57. Sulaiman M., Matta M.J., Sunderesan N.R., Gupta M.P., Periasamy M., Gupta M. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H833-H843.
58. Samarel A.M. IGF-1 overexpression rescues the failing heart. Circ. Res. 2002, 90:631-633.
59. Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc. Res. 1995, 30:825-834.
60. Kajstura J., Fiordaliso F., Andreoli A.M., et al. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001, 50:1414-1424.
61. Duerr R.L., McKirnan M.D., Gim R.D., Clark R.G., Chien K.R., Ross J. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 1996, 93:2188-2196.
62. Norby F.L., Wold L.E., Duan J., Hintz K.K., Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E658-E666.
63. Li Q., Wu S., Li S.Y., et al. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1398-H1403.
64. Lyon A.R., Bannister M.L., Collins T., et al. SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure. Circ. Arrhyth. Electrophysiol. 2011, 4:362-372.
65. Kumarswamy R., Lyon A.R., Volkmann I., et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur. Heart J. 2012, 33:1067-1075.
66. 2+ handling in normal and diabetic rat hearts. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2002, 16:1657-1659.
67. Trost S.U., Belke D.D., Bluhm W.F., Meyer M., Swanson E., Dillmann W.H. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 2002, 51:1166-1171.
68. Karakikes I., Kim M., Hadri L., et al. Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a. PLoS ONE 2009, 4:e6474.
69. Suarez J., McDonough P.M., Scott B.T., et al. Sorcin modulates mitochondrial Ca(2+) handling and reduces apoptosis in neonatal rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 2013, 304:C248-C256.
70. Suarez J., Belke D.D., Gloss B., et al. In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H68-H75.
71. 2+-ATPase activity and left ventricular function in STZ-induced diabetic rats. Biomed. Environ. Sci. 2013, 26:577-583.
72. 2+-ATPase in patients with advanced heart failure. Circulation 2011, 124:304-313.
73. Rorsman P., Braun M. Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol. 2013, 75:155-179.
74. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
75. Berridge M.J. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 2002, 32:235-249.
76. Varadi A., Molnar E., Ashcroft S.J. Characterisation of endoplasmic reticulum and plasma membrane Ca(2+)-ATPases in pancreatic beta-cells and in islets of Langerhans. Biochim. Biophys. Acta 1995, 1236:119-127.
77. Varadi A., Molnar E., Ostenson C.G., Ashcroft S.J. Isoforms of endoplasmic reticulum Ca(2+)-ATPase are differentially expressed in normal and diabetic islets of Langerhans. Biochem. J. 1996, 319(Pt. 2):521-527.
78. 2+ oscillations in pancreatic islets. Bull. Math. Biol. 2008, 70:1251-1271.
79. 2+ sequestration in diabetic mouse islets of Langerhans. J. Biol. Chem. 1994, 269:18279-18282.
80. 2+-ATPases in muscle and heart. J. Biol. Chem. 1997, 272:23696-23702.
81. 2+-ATPase (SERCA)-2b and -3. Diabetes 2004, 53:1517-1525.
82. Varadi A., Lebel L., Hashim Y., Mehta Z., Ashcroft S.J., Turner R. Sequence variants of the sarco(endo)plasmic reticulum Ca(2+)-transport ATPase 3 gene (SERCA3) in Caucasian type II diabetic patients (UK Prospective Diabetes Study 48). Diabetologia 1999, 42:1240-1243.
83. Arredouani A., Guiot Y., Jonas J.C., et al. SERCA3 ablation does not impair insulin secretion but suggests distinct roles of different sarcoendoplasmic reticulum Ca(2+) pumps for Ca(2+) homeostasis in pancreatic beta-cells. Diabetes 2002, 51:3245-3253.
84. 2+ and insulin release in glucose-stimulated pancreatic islets. J. Biol. Chem. 1994, 269:8749-8753.
85. 2+-ATPase of the endoplasmic reticulum. Am. J. Physiol. Cell Physiol. 2006, 290:C1503-C1511.
86. Evans-Molina C., Robbins R.D., Kono T., et al. Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Mol. Cell. Biol. 2009, 29:2053-2067.
87. 2+ is important for the proteolytic processing and intracellular transport of proinsulin in the pancreatic beta-cell. Biochem. J. 1997, 323(Pt. 2):445-450.
88. Eizirik D.L., Mandrup-Poulsen T. A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001, 44:2115-2133.
89. 2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 2005, 54:452-461.
90. Kono T., Ahn G., Moss D.R., et al. PPAR-gamma activation restores pancreatic islet SERCA2 levels and prevents beta-cell dysfunction under conditions of hyperglycemic and cytokine stress. Mol. Endocrinol. 2012, 26:257-271.
91. Groenendyk J., Sreenivasaiah P.K., Kim do H., Agellon L.B., Michalak M. Biology of endoplasmic reticulum stress in the heart. Circ. Res. 2010, 107:1185-1197.
92. Gomez E., Powell M.L., Bevington A., Herbert T.P. A decrease in cellular energy status stimulates PERK-dependent eIF2alpha phosphorylation and regulates protein synthesis in pancreatic beta-cells. Biochem. J. 2008, 410:485-493.
93. Moore C.E., Omikorede O., Gomez E., Willars G.B., Herbert T.P. PERK activation at low glucose concentration is mediated by SERCA pump inhibition and confers preemptive cytoprotection to pancreatic beta-cells. Mol. Endocrinol. 2011, 25:315-326.
94. 2+ channels in endoplasmic reticulum stress and beta-cell death. Diabetes 2009, 58:422-432.